Therapeutic roles of CAR T cells in infectious diseases: Clinical lessons learnt from cancer-Reference-Cited by-同舟云学术

Therapeutic roles of CAR T cells in infectious diseases: Clinical lessons learnt from cancer

Published:2022-01-17 Issue:4 Volume:32 Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Reviews in Medical Virology

Author:

Mohammadi Mahsa¹²^ORCID,Akhoundi Maryam¹,Malih Sara³⁴^ORCID,Mohammadi Ali⁵⁶^ORCID,Sheykhhasan Mohsen⁷⁸^ORCID

Affiliation:

1. Department of Stem Cells and Developmental Biology Cell Science Research Center Royan Institute for Stem Cell Biology and Technology ACECR Tehran Iran

2. Department of Developmental Biology University of Science and Culture Tehran Iran

3. Department of Radiology University of Wisconsin‐Madison Madison Wisconsin USA

4. Department of Medical Biotechnology Faculty of Medical Sciences, Tarbiat Modares University Tehran Iran

5. School of Medicine Tehran University of Medical Sciences Tehran Iran

6. School of Medicine Lorestan University of Medical Sciences Khorramabad Iran

7. Research Center for Molecular Medicine Hamadan University of Medical Sciences Hamadan Iran

8. Department of Mesenchymal Stem Cells The Academic Center for Education, Culture and Research Qom Iran

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2325

Reference177 articles.

1. Tisagenlecleucel — the first approved CAR-T-cell therapy: implications for payers and policy makers

2. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

3. The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma

4. Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed and refractory multiple myeloma (RRMM): Initial KarMMa results.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of MIDD to accelerate the development of anti-infectives: Current status and future perspectives;Advanced Drug Delivery Reviews;2024-09

2. Bispecific T-Cell Engagers (BiTEs) in Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

3. Advancement in “Off-the-Shelf” CAR T-Cell Therapy for Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

4. Recent Updates on Chimeric Antigen Receptor T-Cell Approaches in Cancer Immunotherapy;Advances in Cancer Immunotherapy [Working Title];2024-05-15

5. Next-generation treatments: Immunotherapy and advanced therapies for COVID-19;Heliyon;2024-03